DNA & Genetics OGT expands MRD detection capabilities with new SureSeq Myeloid MRD Plus NGS PanelBy adminNovember 15, 20250 Today, OGT announced the launch of a new next-generation sequencing (NGS) panel for Measurable Residual Disease (MRD) – the SureSeq™…
